Dovitinib(TKI258) in Patients With Castration-resistant Prostate Cancer

Clinical trial NCT01741116 · COMPLETED

Trial details

NCT number: NCT01741116
Sponsor: Korean Cancer Study Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone Refractory Prostate Cancer

Start date: 2012-11-01
Primary completion: 2014-12-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.